News - Regulation, Global

Filter

Current filters:

RegulationGlobal

Popular Filters

1 to 25 of 37 results

Lucrative biosimilars space to erode biologics market from 2019

Lucrative biosimilars space to erode biologics market from 2019

11-06-2014

The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market…

BiosimilarsBiotechnologyGlobalMarkets & MarketingRegulation

European generics group welcomes WHA resolution on biotherapeutics products

04-06-2014

The European Generic Medicines Association (EGA) has welcomed the 67th World Health Assembly’s Resolution…

BiosimilarsGenericsGlobalRegulation

EGA calls for international regulatory cooperation

03-06-2014

European Generics Medicines Association (EGA) Director General Adrian van den Hoven last week joined…

GenericsGlobalPharmaceutical industryRegulationResearch

Global Fund taps pharmaceutical expertise in China

02-04-2014

The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

IFPMA and the Global Fund collaborate to help protect patients from fake medicines

05-12-2013

The International Federation of Pharmaceutical Manufacturers and Associations and the Global Fund to…

Anti-viralsAntibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalRegulationTropical diseases

Three big predictions for the global health care market

04-12-2013

Three big predictions for the global health care market have been released by market research firm Frost…

GlobalMarkets & MarketingPharmaceuticalRegulation

Newly accessible Japanese encephalitis vaccine will make saving children easier in developing countries

09-10-2013

A newly accessible vaccine against Japanese encephalitis which will make the protection of more children…

China National BiotecGlobalPharmaceuticalRegulationVaccines

WHO implements fee changes to its Prequalification of Medicines Program

10-09-2013

Fee changes have come into force in the World Health Organization Prequalification of Medicines Program…

GlobalPharmaceuticalRegulation

US FDA fast-tracks Elan's Alzheimer's drug candidate

18-07-2013

Ireland-based Elan Corp (NYSE: ELN) says that the US Food and Drug Administration has granted Fast Track…

ElanELND005GlobalMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalRegulation

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards

03-07-2013

From July 2, 2013, all active substances manufactured outside of the European Union and imported into…

EuropeGenericsGlobalPharmaceuticalProductionRegulation

Pace of drug approvals to moderate for global pharma companies, says Fitch Ratings

21-05-2013

Global pharmaceutical novel drug approvals will moderate in 2013 due to the exceptional research success…

BiotechnologyGlobalNorth AmericaPharmaceuticalRegulationResearch

Launching new drugs in the Outcome Era; report

15-05-2013

The pharmaceutical industry is facing the Outcome Era. Launching a novel drug today obliges companies…

GlobalMarkets & MarketingPharmaceuticalPricingRegulation

Europe falling behind USA and China as attractive for life sciences sector

22-04-2013

Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…

BiotechnologyFinancialGlobalPatentsPharmaceuticalRegulationResearch

Support for introduction of a global regulatory process for biosimilars

16-04-2013

The majority of surveyed US and European physicians and payers are in favor of the introduction of a…

BiotechnologyGenericsGlobalRegulationResearch

EMA reports on patient recruitment and geographical location of clinical trials

10-04-2013

Almost 62% of the patients in pivotal trials submitted in marketing-authorisation applications (MAAs)…

BiotechnologyEuropeGlobalPharmaceuticalRegulationResearch

INTERPOL and Pharma launch global initiative to combat fake medicines

12-03-2013

Combating the global scourge of fake medicines, which threatens the health of millions of people, is…

GlobalMarkets & MarketingPharmaceuticalRegulation

OECD urges harmonization of clinical trial regulations to boost medical R&D

25-02-2013

Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and…

BiotechnologyGlobalPharmaceuticalRegulationResearch

Sales of antiretroviral agents for HIV will decline slightly over next decade

18-12-2012

Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

Zeltia's Yondelis approved for sale in 10 new countries

04-12-2012

Pharma Mar, a subsidiary of Spain's Grupo Zeltia (ZEL: MC), says it has been advised by its licensee…

GlobalJanssenJohnson & JohnsonOncologyPharmaceuticalPharmaMarRegulationYondelisZeltia

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

03-12-2012

Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

A blip or stark reality? Pharma companies re-evaluate emerging markets

28-08-2012

Pharmaceutical companies, which have previously been allaying the growing fears and concerns of their…

FinancialGlobalMarkets & MarketingPharmaceuticalPricingRegulation

1 to 25 of 37 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top